Literature DB >> 6317065

Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action.

H A Sackeim, P Decina, I Prohovnik, S Malitz, S R Resor.   

Abstract

The efficacy of electroconvulsive therapy (ECT) in the treatment of affective disorders is well established. Despite its clinical utility, there is no generally accepted theory regarding its mode of action. Several lines of evidence indicate that ECT has significant anticonvulsant properties and results in decreased neural metabolic activity. We suggest that these effects are due to enhanced gamma-aminobutyric acid (GABA) transmission and that localized suppression of neural metabolic activity is associated with therapeutic response to ECT. An implication of this view is that ECT may be a useful adjunctive treatment in intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317065

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  27 in total

Review 1.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 2.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

Authors:  Gislaine Zilli Réus; Airam Barbosa de Moura; Laura Araújo Borba; Helena Mendes Abelaira; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2019-05-21

Review 3.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 4.  Guide to anaesthetic selection for electroconvulsive therapy.

Authors:  Klaus J Wagner; Oliver Möllenberg; Michael Rentrop; Christian Werner; Eberhard F Kochs
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Device-Based Modulation of Neurocircuits as a Therapeutic for Psychiatric Disorders.

Authors:  Zhi-De Deng; Bruce Luber; Nicholas L Balderston; Melbaliz Velez Afanador; Michelle M Noh; Jeena Thomas; William C Altekruse; Shannon L Exley; Shriya Awasthi; Sarah H Lisanby
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-01-06       Impact factor: 13.820

6.  Polymorphism of the brain-derived neurotrophic factor and dynamics of the seizure threshold of electroconvulsive therapy.

Authors:  C Stephani; M Shoukier; R Ahmed; C Wolff-Menzler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-27       Impact factor: 5.270

Review 7.  Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician.

Authors:  Mario A Cristancho; Yesne Alici; John G Augoustides; John P O'Reardon
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 8.  Advances in the treatment of depression.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  NeuroRx       Date:  2006-01

9.  Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

Authors:  Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand
Journal:  Brain Stimul       Date:  2008-04       Impact factor: 8.955

10.  Electroconvulsive therapy for refractory status epilepticus: a case series.

Authors:  Hooman Kamel; Susannah Brock Cornes; Manu Hegde; Stephen E Hall; S Andrew Josephson
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.